OBJECTIVE: Historically marginalized groups are likely to be exposed to social adversity, which predicts important mental health outcomes (e.g., depression). Despite the well-established relationship between adversity and poor health, few studies have examined how adversity differentially predicts mental health among people living with multiple, co-occurring marginalized identities or statuses. The current study fills this gap by examining whether relationships between social adversity and depressive symptoms differed between those living with or without a stigmatized disease (i.e., HIV) and/or marginalized racial/ethnic identity (i.e., African American). METHOD: A community sample of men and women (N = 149) completed questionnaires assessing demographics and depressive symptoms. Additionally, a composite index of social adversity was derived from measures of perceived discrimination, socioeconomic status, financial restriction to receiving medical care, and perceived neighborhood characteristics. Multiple regression was used to test whether relationships between adversity and depressive symptoms differed as a function of HIV status and racial/ethnic identity. RESULTS: A significant 3-way interaction between social adversity, HIV status, and racial/ethnic identity indicated that there was a direct relationship between adversity and depressive symptoms for HIV-positive (HIV+) African Americans but not for HIV-negative (HIV-) African Americans, HIV+ Caucasians, or HIV- Caucasians. Further, HIV+ African Americans evidenced a significantly greater relationship between adversity and depressive symptoms compared with HIV- African Americans, but not compared with other groups. CONCLUSIONS: The findings suggest that HIV+ African Americans may be at risk for higher depressive symptoms amid adversity, highlighting the importance of evaluating intersectional identities/statuses in the context of mental health. (PsycINFO Database Record (c) 2017 APA, all rights reserved).
OBJECTIVE: Historically marginalized groups are likely to be exposed to social adversity, which predicts important mental health outcomes (e.g., depression). Despite the well-established relationship between adversity and poor health, few studies have examined how adversity differentially predicts mental health among people living with multiple, co-occurring marginalized identities or statuses. The current study fills this gap by examining whether relationships between social adversity and depressive symptoms differed between those living with or without a stigmatized disease (i.e., HIV) and/or marginalized racial/ethnic identity (i.e., African American). METHOD: A community sample of men and women (N = 149) completed questionnaires assessing demographics and depressive symptoms. Additionally, a composite index of social adversity was derived from measures of perceived discrimination, socioeconomic status, financial restriction to receiving medical care, and perceived neighborhood characteristics. Multiple regression was used to test whether relationships between adversity and depressive symptoms differed as a function of HIV status and racial/ethnic identity. RESULTS: A significant 3-way interaction between social adversity, HIV status, and racial/ethnic identity indicated that there was a direct relationship between adversity and depressive symptoms for HIV-positive (HIV+) African Americans but not for HIV-negative (HIV-) African Americans, HIV+ Caucasians, or HIV- Caucasians. Further, HIV+ African Americans evidenced a significantly greater relationship between adversity and depressive symptoms compared with HIV- African Americans, but not compared with other groups. CONCLUSIONS: The findings suggest that HIV+ African Americans may be at risk for higher depressive symptoms amid adversity, highlighting the importance of evaluating intersectional identities/statuses in the context of mental health. (PsycINFO Database Record (c) 2017 APA, all rights reserved).
Authors: R Andersen; S Bozzette; M Shapiro; P St Clair; S Morton; S Crystal; D Goldman; N Wenger; A Gifford; A Leibowitz; S Asch; S Berry; T Nakazono; K Heslin; W Cunningham Journal: Health Serv Res Date: 2000-06 Impact factor: 3.402
Authors: M F Shapiro; S C Morton; D F McCaffrey; J W Senterfitt; J A Fleishman; J F Perlman; L A Athey; J W Keesey; D P Goldman; S H Berry; S A Bozzette Journal: JAMA Date: 1999 Jun 23-30 Impact factor: 56.272
Authors: Jori A Berger-Greenstein; Carlos A Cuevas; Stephen M Brady; Glenn Trezza; Mark A Richardson; Terence M Keane Journal: AIDS Patient Care STDS Date: 2007-12 Impact factor: 5.078
Authors: Susan Herrmann; Elizabeth McKinnon; Noel B Hyland; Christophe Lalanne; Simon Mallal; David Nolan; Olivier Chassany; Martin Duracinsky Journal: Health Qual Life Outcomes Date: 2013-04-08 Impact factor: 3.186
Authors: April D Thames; Taylor P Kuhn; Zanjbeel Mahmood; Robert M Bilder; Timothy J Williamson; Elyse J Singer; Alyssa Arentoft Journal: Brain Imaging Behav Date: 2018-02 Impact factor: 3.978
Authors: Tahilin Sanchez Karver; Kaitlyn Atkins; Virginia A Fonner; Carlos E Rodriguez-Diaz; Michael D Sweat; Tamara Taggart; Ping Teresa Yeh; Caitlin E Kennedy; Deanna Kerrigan Journal: Am J Public Health Date: 2022-06 Impact factor: 11.561
Authors: Janet M Turan; Melissa A Elafros; Carmen H Logie; Swagata Banik; Bulent Turan; Kaylee B Crockett; Bernice Pescosolido; Sarah M Murray Journal: BMC Med Date: 2019-02-15 Impact factor: 8.775
Authors: Timothy J Williamson; Jamie S Ostroff; Chloé M Martin; Smita C Banerjee; Carma L Bylund; Heidi A Hamann; Megan Johnson Shen Journal: Patient Educ Couns Date: 2020-08-11